BiotechTube
Home/Calviri/Kathryn Sykes, PhD
KS

Kathryn Sykes, PhD

VP Research & Product Development, Co-Founder, Director

Calviri

Therapeutic Areas

Oncology

Calviri Pipeline

DrugIndicationPhase
StageOne PlusCanine Multi-Cancer DetectionCommercial
VACCSCanine Preventative Cancer VaccineTrial Completed
SOCHCanine Stage 1 Hemangiosarcoma Therapeutic VaccinePhase 1/2
FixVax (Canine)Canine Multi-Cancer Therapeutic VaccinePreclinical
DiagnosticHuman Breast Cancer Recurrence MonitoringPreclinical

Leadership Team at Calviri

SA
Stephen Albert Johnston, PhD/PhD
CEO, Co-Founder, Director
JL
Jeffrey Le Benger, MD, FACS
Chairman of the Board
JS
Jacque Sokolov, MD
Director
MM
Michael McAllister
Director
View full Calviri profile